Abstract
BACKGROUND:This study evaluated the efficacy of photochemical treatment (PCT) with amotosalen and ultraviolet A (UVA) light to inactivateTrypanosoma cruziin contaminated platelet (PLT) components.STUDY DESIGN AND METHODS:Fifteen pools of buffy‐coat PLTs (BC‐PLTs) were inoculated with approximately 5 × 103to 5 × 105per mL of viableT. cruziof the G, Tulahuen (T), or Y strains. Samples from BC‐PLTs were assayed for infectivity before and after PCT with 150 µmol per L amotosalen and 3 J per cm2UVA light. Infectivity was determined with three different methods: 1) in vitro culture to detect viable epimastigotes, 2) [3H]thymidine incorporation in culture, and 3) in vivo inoculation into interferon‐γ receptor (IFN‐γR)‐deficient mice.RESULTS:The in vitro assay yielded viable parasite titers of 3.9 × 105, 2.8 × 104, and 5.6 × 103per mL (corresponding to 5.6, 4.4, and 3.8 logs/mL) for the Y, T, and G strains, respectively. PCT was able to inactivate all three strains ofT. cruzito below the limit of detection (10 parasites/mL) in the sensitive in vivo assay. Because 10‐mL samples, each concentrated into a 1‐mL sample for inoculation, were tested in the in vivo assay, log reductions achieved were greater than 5.6, greater than 4.4, and greater than 3.8 for the Y, T, and G strains ofT. cruzi, respectively.CONCLUSIONS:The pathogen reduction system with amotosalen HCl and UVA demonstrated robust efficacy for inactivation of high doses of three different strains ofT. cruziand offers the potential to make the PLT supply safer.

This publication has 24 references indexed in Scilit: